{
    "title": "Confirmatory validation of the french version of the Duchenne Muscular Dystrophy module of the pediatric quality of life inventory (PedsQL(TM)3.0DMDfv).",
    "doc_id": "37968589",
    "writer": "Wallach E",
    "year": "2023",
    "summary": "The new therapeutic strategies aim to both improve survival and optimise quality of life. Evaluating quality of life is nevertheless a major challenge. No DMD-specific quality of life scale to exists in French. We therefore produced a Fre â€¦",
    "abstract": "Duchenne Muscular Dystrophy (DMD) is a neuromuscular disease that inevitably leads to total loss of autonomy. The new therapeutic strategies aim to both improve survival and optimise quality of life. Evaluating quality of life is nevertheless a major challenge. No DMD-specific quality of life scale to exists in French. We therefore produced a French translation of the English Duchenne Muscular Dystrophy module of the Pediatric Quality of Life Inventory (PedsQLTMDMD) following international recommendations. The study objective was to carry out a confirmatory validation of the French version of the PedsQLTMDMD for paediatric patients with DMD, using French multicentre descriptive cross-sectional data. The sample consisted of 107 patients. Internal consistency was acceptable for proxy-assessments, with Cronbach's alpha coefficients above 0.70, except for the Treatment dimension. For self-assessments, internal consistency was acceptable only for the Daily Activities dimension. Our results showed poor metric qualities for the French version of the PedsQLTMDMD based on a sample of about 100 children, but these results remained consistent with those of the original validation. This confirms the interest of its use in clinical practice.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/37968589/",
    "clean_text": "confirmatory validation of the french version of the duchenne muscular dystrophy module of the pediatric quality of life inventory pedsql tm dmdfv the new therapeutic strategies aim to both improve survival and optimise quality of life evaluating quality of life is nevertheless a major challenge no dmd specific quality of life scale to exists in french we therefore produced a fre duchenne muscular dystrophy dmd is a neuromuscular disease that inevitably leads to total loss of autonomy the new therapeutic strategies aim to both improve survival and optimise quality of life evaluating quality of life is nevertheless a major challenge no dmd specific quality of life scale to exists in french we therefore produced a french translation of the english duchenne muscular dystrophy module of the pediatric quality of life inventory pedsqltmdmd following international recommendations the study objective was to carry out a confirmatory validation of the french version of the pedsqltmdmd for paediatric patients with dmd using french multicentre descriptive cross sectional data the sample consisted of patients internal consistency was acceptable for proxy assessments with cronbach s alpha coefficients above except for the treatment dimension for self assessments internal consistency was acceptable only for the daily activities dimension our results showed poor metric qualities for the french version of the pedsqltmdmd based on a sample of about children but these results remained consistent with those of the original validation this confirms the interest of its use in clinical practice"
}